Skip to main content
SpringerLink
Log in

Coronary Artery Surgery for Ischaemic Heart Failure: The Surgeon's View

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Recent advances in medical therapy have improved outcomes for patients with severe heart failure. However, overall survival remains poor. Transplantation is an established therapy for these patients but is limited by the large mismatch between demand and donor organ availability.

Recently it has been recognised that not all ventricular dysfunction secondary to coronary artery disease is irreversible. Revascularisation in certain patients would appear to improve ventricular function. These patients are said to demonstrate myocardial “hibernation”. Revascularisation in these patients may provide a further treatment option in the treatment of heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cowie MR et al. Incidence and aetiology of heart failure: A population-based study (see comments). European Heart Journal 1999;20:421–428.

    Google Scholar 

  2. Pfeffer MA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators (see comments). New England Journal of Medicine 1992;327:669–677.

    Google Scholar 

  3. Anonymous. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial (see comments). Lancet 1999;353:9–13.

    Google Scholar 

  4. Anonymous. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The acute infarction ramipril ef-ficacy (AIRE) study investigators (see comments). Lancet 1993;342:821–828.

    Google Scholar 

  5. Kober L et al. A clinical trial of the angiotensin-convertingenzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril cardiac evaluation (TRACE) study group (see comments). New England Journal of Medicine 1995;333:1670–1676.

    Google Scholar 

  6. Rahimtoola SH. The hibernating myocardium (see comments). American Heart Journal 1989;117:211–221.

    Google Scholar 

  7. Lee KS et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687–2694.

    Google Scholar 

  8. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? Circulation 1989;79:441–444.

    Google Scholar 

  9. Pagano D et al. Coronary revascularisation for postischaemic heart failure: How myocardial viability affects survival. Heart 1999;82:684–688.

    Google Scholar 

  10. Diamond GA. Hibernating myocardium (letter; comment). American Heart Journal 1989;118:1361.

    Google Scholar 

  11. Cornel JH et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: Implications of time course of recovery on diagnostic accuracy. Journal of the American College of Cardiology 1998;31:1002–1010.

    Google Scholar 

  12. Tillisch J et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. New England Journal of Medicine 1986;314:884–888.

    Google Scholar 

  13. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. Journal of the American College of Cardiology 1999;33:1848–1854.

    Google Scholar 

  14. Pasquet A et al. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction (erratum appears in circulation 1999 Oct. 5;100(14):1584). Circulation 1999;100:141–148.

    Google Scholar 

  15. Eitzman D et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography (see comments). Journal of the American College of Cardiology 1992;20:559–565.

    Google Scholar 

  16. Alderman EL et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785–795.

    Google Scholar 

  17. Bounous EP et al. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 1988;78:I151–I157.

    Google Scholar 

  18. Hochberg MS, Parsonnet V, Gielchinsky I, Hussain SM. Coronary artery bypass grafting in patients with ejection fractions below forty percent. Early and late results in 466 patients. Journal of Thoracic & Cardiovascular Surgery 1983; 86: 519–527.

    Google Scholar 

  19. Pigott JD, Kouchoukos NT, Oberman A, Cutter GR. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. Journal of the American College of Cardiology 1985;5:1036–1045.

    Google Scholar 

  20. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina (review) (42 refs). Circulation 1985;72:V123–V135.

    Google Scholar 

  21. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: Evidence for the "hibernating myocardium". Journal of the American College of Cardiology 1986;8:1467–1470.

    Google Scholar 

  22. Di Carli MFet al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions. Journal of Thoracic & Cardiovascular Surgery 1998;116:997–1004.

    Google Scholar 

  23. Bax JJ et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. Journal of the American College of Cardiology 1999;34:163–169.

    Google Scholar 

  24. Auerbach MA et al. Prevalence of myocardial viability as detected by positron emission tomography in patients CABG for Ischaemic Heart Failure 179 with ischemic cardiomyopathy (see comments). Circulation 1999;99:2921–2926.

    Google Scholar 

  25. Haas F et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease (see comments). Journal of the American College of Cardiology 1997;30:1693–1700.

    Google Scholar 

  26. Meluzin J et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this multicenter study. Journal of the American College of Cardiology 1998;32:912–920.

    Google Scholar 

  27. Bax JJ et al. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. Journal of the American College of Cardiology 1997;30:377–383.

    Google Scholar 

  28. Beanlands RS et al. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998;98:II51–II56.

    Google Scholar 

  29. Di Carli MFet al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. American Journal of Cardiology 1994;73:527–533.

    Google Scholar 

  30. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793–800.

    Google Scholar 

  31. Afridi I et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. Journal of the American College of Cardiology 1998;32:921–926.

    Google Scholar 

  32. Chaudhry FA et al. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. Journal of the American College of Cardiology 1999;34:730–738.

    Google Scholar 

  33. Schwarz ER et al. Myocyte degeneration and cell death in hibernating human myocardium. Journal of the American College of Cardiology 1996;27:1577–1585.

    Google Scholar 

  34. Schwarz ER et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. Journal of the American College of Cardiology 1998;31:1018–1026.

    Google Scholar 

  35. Louie HW et al. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation 1991;84:III290–III295.

    Google Scholar 

  36. Luciani GB et al. Severe ischemic left ventricular failure: Coronary operation or heart transplantation? Annals of Thoracic Surgery 1993;55:719–723.

    Google Scholar 

  37. Milano CA et al. Coronary artery bypass in patients with severely depressed ventricular function. Annals of Thoracic Surgery 1993;56:487–493.

    Google Scholar 

  38. Mickleborough LL et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92:II73–II79.

    Google Scholar 

  39. Pagano D et al. Coronary artery bypass surgery as treatment for ischemic heart failure: The predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. Journal of Thoracic & Cardiovascular Surgery 1998;115:791–799.

    Google Scholar 

  40. Dreyfus GD et al. Myocardial viability assessment in ischemic cardiomyopathy: Benefits of coronary revascularization. Annals of Thoracic Surgery 1994;57:1402–1407; discussion 1407–1408.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiac Surgery, Queen Elizabeth Hospital Medical Centre, Edgbaston, Birmingham, B15 2TH

    Michael Edward Lewis, Michael Paul Ian Pitt, Robert Stuart Bonser & Domenico Pagano

Authors
  1. Michael Edward Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Paul Ian Pitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Stuart Bonser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Domenico Pagano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Pagano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, M.E., Pitt, M.P.I., Bonser, R.S. et al. Coronary Artery Surgery for Ischaemic Heart Failure: The Surgeon's View. Heart Fail Rev 8, 175–179 (2003). https://doi.org/10.1023/A:1023049020136

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023049020136

Search

Navigation